Press "Enter" to skip to content

Pharmacovigilance Market 2019 Research Methodology, Business Plans, Development Status, and Industry Size & Share Forecast to 2024

Pharmacovigilance

The “Pharmacovigilance Market” report 2019 provides a comprehensive analysis of Pharmacovigilance industry by types, applications, key players and regions. It shows the Pharmacovigilance market 2019-2024 by production, consumption, supply, gross margin, the revenue of the industry. Additionally, the Pharmacovigilance market report covers the details of market size, share, and growth rate of the market with respect to regions.

Get a Sample Copy of the Report At – https://www.industryresearch.co/enquiry/request-sample/14099022

Competitor Analysis:

Pharmacovigilance market includes the following leading manufacturers on the basis of sales, revenue, price, and gross margin.

  • Accenture
  • Cognizant
  • Laboratory Corporation of America Holdings
  • IBM Corporation
  • ArisGlobal
  • Foresight Group International AG
  • ICON PLC
  • Capgemini
  • United BioSource Corporation
  • Wipro Ltd
  • BioClinica

    Market Overview:

  • The key factors propelling this market are increasing drug consumption and drug development rates, growing incidence rates of adverse drug reactions and drug toxicity, and increasing trend of outsourcing pharmacovigilance services. The increasing incidence of lifestyle diseases, such as diabetes, hypertension, and cardiac disorders, as a result of sedentary lifestyles, lack of physical activities, changing lifestyle patterns, and poor diets lead to increasing consumption of drugs, which, in turn, indicates the high demand for drug monitoring and further fuels the growth of the pharmacovigilance market. With the growing drug consumption, the need for the regular monitoring of drugs has also augmented, eventually boosting the pharmacovigilance market. Human infectious diseases are also on rising due to the changing climate, pervasive poverty, and increasing urbanization, which also surge drug consumption and drive the drug development process. Furthermore, new drug developments need to get regulated and stimulate the overall pharmacovigilance market.

    Pharmacovigilance market report presents in-depth analysis regarding the development, current trends, industry policies and regulations implemented in each of the geographical region. It includes analysis of upstream raw materials, downstream demand, and current market dynamics. Furthermore, the Pharmacovigilance market report provides in-depth insight of Pharmacovigilance industry during 2019-2024.

    Scope of the Report:

  • Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The focus of pharmacovigilance is on ADR (adverse drug reactions) and drug toxicity. The pharmacovigilance market comprises of all types of adverse events reporting conducted during clinical trials in hospitals, pharmacies, and other healthcare sectors.

    Inquire or Share Your Questions If Any Before the Purchasing This Report – https://www.industryresearch.co/enquiry/pre-order-enquiry/14099022

    Key Market Trends:

    Pharmaceutical Companies are Expected to Hold the Highest Market Share in the End User Segment

    In the end user segment of the pharmacovigilance market, pharmaceutical companies are believed to have the largest market size.

    The role of pharmaceutical companies is to invest in the R&D of new compounds, have the commitment to bring a new drug to market to enhance the patients’ health and quality of life, strict governance to conduct clinical trials, product development activities as well as conduct relations with patients and healthcare professionals in accordance with ethical and legal principles. A major pharmaceutical company, such as Astra, has over 100 permanent, experienced staff in pharmacovigilance within its R&D organization in Sweden and the United Kingdom, and a similar number in local operating companies worldwide. This development has been driven by the increased recognition of the role of pharmacovigilance, the investigation, and marketing of a wider range of diverse medicinal products and more stringent and detailed regulatory requirements.

    Such developments that are occurring in the pharmaceutical companies are helping the pharmacovigilance market grow.

    North America Dominates the Market and Expected to do Same in the Forecast Period

    North America currently dominates the market for pharmacovigilance and is expected to continue its stronghold for a few more years. Due to the shifting of high costs of in-house pharmacovigilance activities to CROs, the pharmacovigilance system in the United States is moving from a passive to a proactive role in the healthcare system. According to a 2017 publication in the Journal of American Medical Association, one out of three drugs in the United States may have the safety issues. Therefore, a need for modifying the current protocols for quick communication between healthcare providers and the FDA needs to be strengthened. Additionally, as more biosimilars would be available in the near future, accurately matching the adverse event is highly important. With that, the United States has a large market share of 56% in North America and is expected to register a growth rate of 12.3% over the forecast period.

    Reasons to Buy Pharmacovigilance Market Report:

    • Analysis of Pharmacovigilance market including revenues, future growth, market outlook
    • Historical data and forecast of Pharmacovigilance industry
    • Pharmacovigilance market report covers regional analysis including growth estimates
    • To analyze the end user markets including growth estimates
    • Profiles on laboratory balance including products, sales/revenues, and market position
    • Includes Pharmacovigilance market structure, market drivers, opportunities, and restraints.

    Purchase this Report (Price 4250 USD for a Single-User License) – https://www.industryresearch.co/purchase/14099022

    Pharmacovigilance Market Report Covers the Following Questions:

    • What trends, challenges and barriers are influencing its growth?
    • What is the and regional outlook for Pharmacovigilance market?
    • Who are the key players, and what are their strategies?
    • What is the status of Pharmacovigilance status worldwide?
    • What are the Pharmacovigilance market challenges to market growth? 
    • What are the Pharmacovigilance market challenges to market growth? 
    • What are the types and applications of Pharmacovigilance ?
    • What is the market share of each type and application? 

    Detailed TOC of Pharmacovigilance Market 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Drug Consumption And Drug Development Rates
    4.2.2 Growing incidence rates of ADR and drug toxicity
    4.2.3 Increasing trend of outsourcing pharmacovigilance services
    4.3 Market Restraints
    4.3.1 High risk associated with data security
    4.3.2 Lack of global regulatory harmonization and lack of data standardization for adverse event collection
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Clinical Trial Phase
    5.1.1 Preclinical
    5.1.2 Phase I
    5.1.3 Phase II
    5.1.4 Phase III
    5.1.5 Phase IV
    5.2 Service Provider
    5.2.1 In house
    5.2.2 Contract Outsourcing
    5.3 Type of Reporting
    5.3.1 Spontaneous Reporting
    5.3.2 Intensified ADR Reporting
    5.3.3 Targeted Spontaneous Reporting
    5.3.4 Cohort Event Monitoring
    5.3.5 EHR Mining
    5.4 End User
    5.4.1 Hospitals
    5.4.2 Pharmaceutical Companies
    5.4.3 Other End Users
    5.5 Geography
    5.5.1 North America
    5.5.1.1 US
    5.5.1.2 Canada
    5.5.1.3 Mexico
    5.5.2 Europe
    5.5.2.1 Germany
    5.5.2.2 UK
    5.5.2.3 France
    5.5.2.4 Italy
    5.5.2.5 Spain
    5.5.2.6 Rest of Europe
    5.5.3 Asia-Pacific
    5.5.3.1 China
    5.5.3.2 Japan
    5.5.3.3 India
    5.5.3.4 Australia
    5.5.3.5 South Korea
    5.5.3.6 Rest of Asia-Pacific
    5.5.4 Middle East & Africa
    5.5.4.1 GCC
    5.5.4.2 South Africa
    5.5.4.3 Rest of Middle East & Africa
    5.5.5 South America
    5.5.5.1 Brazil
    5.5.5.2 Argentina
    5.5.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Accenture
    6.1.2 Cognizant
    6.1.3 Laboratory Corporation of America Holdings
    6.1.4 IBM Corporation
    6.1.5 ArisGlobal
    6.1.6 Foresight Group International AG
    6.1.7 ICON PLC
    6.1.8 Capgemini
    6.1.9 United BioSource Corporation
    6.1.10 Wipro Ltd
    6.1.11 BioClinica

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Blood Testing Market 2019 Comprehensive Research Study, Size, Global Trends, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2024

    Yogurt Market 2019 Comprehensive Research Study, Size, Global Trends, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2024

    Centrifugal Compressor Market 2019-2024 Industry Size, Share, Development History, Current Assessment, Business Strategy, Upcoming Trends of Industry

    2019 Positron Emission Tomography Market Report Leading Countries with Size and Share, Growth Rate, Market Latest Trends, Future Technologies Forecast to 2024